Replies to post #28887 on Therapeutic Solutions International Inc (TSOI)

[centsability4me]

This Post-Effective Amendment No. 1 relates to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-236338), initially filed by the Registrant on 02/10/2020 and declared effective by the Securities and Exchange Commission on July 28, 2020. The Registrant is filing this Post-Effective Amendment No. 1 pursuant to 462(c) and Rule 415(a)(3), which requires that a shelf registrant comply with Item 512(a) of Regulation S-K, 17 C.F.R. § 229.512(a)(ii) , which requires that a registrant file a post-effective amendment to an initial registration statement "To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.” Registrant is filing the Post-Effective Amendment No. 1 to reflect a change in the actual price per unit for its common stock sold pursuant to its Registration, as amended. This Post-Effective Amendment No. 1 does not modify any provision of the Registration Statement other than amending the back page for the same purpose of accurately disclosing price-related information as stated above, as set forth below.

https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/83413980/post-effective-amendment-to-registration-statement

The information included in this filing amends this Registration Statement and the prospectus contained therein. No additional securities are being registered under this Post-Effective Amendment No. 1. All applicable registration fees were paid at the time of the original filing of the Registration Statement.

As originally filed and subsequently amended, the registrant’s registration statement, and amendments, indicated the amount to be registered of common shares of registrant’s stock to be 167,848,153, which included 8,000,000 donated shares and 159,848,153 shares to be sold to selling stockholders at a proposed offering price of $.003 per share for an aggregate offering price of $500,000.00 USD. Actual issued shares to selling stockholders was 159,848,153 shares of common stock with the offering price of $500,000.00 USD and an actual share price of $0.00312796857 per unit. There is no change to the registration fee amount.